BIOCOM Work References
The ENABLE project, part of the New Drugs for Bad Bugs (ND4BB) IMI programme, is working to promote the development of potential antibiotics against gram-negative bacteria such as Escherichia coli. The ultimate goal of the project is to develop attractive antimicrobial candidates for clinical testing that bring the possibility of new antibiotics for the treatment of gram-negative infections one step closer to the patient.
A video produced by BIOCOM explains how the implantable, biocompatible microsensor for telemetric intraocular pressure measurement from the medical technology company Implandata works.
The primary objective of the strategy process – initiated by the BMBF – was to establish interdisciplinary links between actors and motivate them to start joint R&D projects. Above all, representatives of the engineering disciplines should be encouraged to consider the use of biotechnological processes and to work together with natural scientists on appropriate solutions.